1 in 3 Alzheimer’s cases could be prevented - here’s what you can do today

Here the medical specialist shares his depth of knowledge about advances in Alzheimer’s disease diagnosis and treatment, the ...

Health Canada Grants Authorization for LEQEMBI® (lecanemab) for the Treatment of Early Alzheimer's Disease

CNW/ - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Canada Inc. announced today that Health ...

FDA clears blood test to help rule out Alzheimer’s disease in people showing symptoms

“To more accurately stage disease and track progression over time ... and confirmatory testing for the amyloid pathology is ...
STAT

Alector’s dementia drug fails to slow patient decline in late-stage trial

An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage ...
News-Medical.Net on MSN

Daily 40Hz audiovisual stimulation may slow cognitive decline in late-onset Alzheimer's patients

A new research paper documents the outcomes of five volunteers who continued to receive 40Hz light and sound stimulation for ...

What is lecanemab, the newly approved Alzheimer’s drug? Can it really slow down dementia?

Dementia is a condition that results in progressive memory or thinking problems. It’s now the most common cause of death in Australia. There are many different causes of dementia, but Alzheimer’s ...
The Canadian Press on MSN

Health Canada authorizes long-awaited drug to slow early-stage Alzheimer's disease

TORONTO — Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease. Lecanemab is the first ...

FDA clears new blood test to help rule out Alzheimer's disease

The U.S. Food and Drug Administration (FDA) has cleared another blood test that could help doctors identify whether a patient ...